Real Estate: Danville homes, Alameda County homes, Contra Costa County homes, Concord homes, Walnut Creek homes, Livermore, East Bay homes, Berkeley, San Ramon Danville Alamo homes, Pleasanton homes, Hayward homes, Orinda Moraga Lafayette homes, Walnut Creek Concord Pleasant Hill homes, Dublin homes, Orinda homes, Moraga homes, Lafayette homes, Antioch, Castro Valley homes, San Ramon homes, San Leandro, Pleasant Hill homes, San Lorenzo, Clayton, Alamo homes
World News   USA   Bay Area   Business   Bio Tech   San Francisco
Homes for Sale in East Bay (San Francisco Bay Area)
San Francisco, Bio Tech Timeline Monday, October 6     Author
To sell or purchase a home in the San Francisco click here
Search Bay Area News Atlas:

Fluidigm pushing forward with IPO  Fluidigm's intrepid drive to complete its initial public offering during one of the most turbulent weeks in Wall Street history has hit gridlock Cell Genesys Drug Trial Halts
World News USA (203) Bay Area Business (1015) Bio Tech (91) San Francisco
2007 (7) 2006 (3) 2005 (1) 2004 (4) 2003 (2) 2002 (2)
   San Francisco (8)    North San Mateo County (29)    Daly City    SF City Hall    SF Downtown    South SF (28)    Genentech (26)
San Francisco on Wikipedia San Francisco on Web San Francisco Books Real Estate 		Fluidigm Withdraws IPO

September 2008 ... more > Top ^

Sep. 25   South SF
  The small company has ended its effort to go public because the turbulence in the financial markets made it impossible to complete the offering
Sep. 19   South SF

August 2008 ... more > Top ^

Aug.27   South SF
  Shares plunged more than 70% after a clinical trial of its cancer vaccine Gvax was stopped due to a higher number of deaths among patients
Aug.21   Genentech Retention plan to cost $371 million  An employee retention plan announced along with its rejection of Roche's buyout offer will cost the biotechnology giant about $371 million Aug.17   Genentech Recruiters eye Genentech employees  While Roche mulls whether to raise its offer price for biotechnology powerhouse, many prized Genentech professionals Aug.13   Genentech Genentech rejects Roche's $43.7b bid
  Biotechnology giant rejected a buyout offer from its majority owner Roche but said it is open to a higher takeover bid
Aug.6   San Francisco Pfizer moving biotech research unit to S.F.
  The world's largest drugmaker will move the headquarters of its new biotech research unit to Mission Bay, next door to UCSF's new campus

July 2008 ... more > Top ^

Jul.31   Genentech Shareholders sue to halt Roche buyout  Shareholders' attorneys are asking a court to invalidate long-standing agreements between Genentech and its majority owner Jul.25   Genentech Panel to ponder Roche takeover offer  Genentech has set up a committee of independent directors to consider Swiss drugmaker offer to acquire all shares it does not already own Jul.21   Genentech Roche Offers $44B For Remaining Shares  Roche Holding, which already owns 55.9%, was offering $43.7 billion to take over the remaining shares of Genentech

April 2008 ... more > Top ^

Apr.30   Genentech Bad news on cancer drug Rituxan  Shares in Genentech sagged, after the company said Rituxan failed to curb symptoms of the debilitating autoimmune disorder Apr.24   Genentech Court slashes $200 million from judgment  The company has been ordered to pay $500 million to a Southern California hospital for failing to pay royalties

February 2008 ... more > Top ^

Feb.22   Genentech FDA Clears Avastin for Breast Cancer
  A Genentech drug received federal approval, a surprise decision
Feb.17   South SF Prostate cancer vaccine shows promise  Shares in Cell Genesys shot up nearly 20% after the company released a favorable analysis of its experimental prostate cancer vaccine GVAX

January 2008 ... more > Top ^

Jan.14   Genentech 4Q Profit Rises 6 Percent  The biotech giant barely scraped past expectations as stock dropped in after-hours trading as sales of a key product also fell below expecta...

year 2007 Top ^

Dec.5   Genentech FDA Panel Rejects Avastin, stock drops  Shares dropped nearly 9% after a panel of medical experts said FDA should deny approval of the company's blockbuster drug Oct.16   Genentech 3Q Profit Up 21 % On Cancer Drug Sales Aug.3   Genentech Genentech completes Tanox acquisition Mar.24   Genentech Genentech projects quarter to be 'flat' Jan.25   San Francisco McKesson's 3rd Qtr. Profit Rises 26%

year 2006 Top ^

Dec.21   Genentech Genentech gets rights to drug Jul.31   Genentech Tony Blair Visits Genentech Headquarters  Heavy hitters from biotech firms sat down for an extraordinary talk with British Prime Minister Feb.13   Genentech Cancer Drug Trials Scaled Back  Avastin only targets cancer, and leaves healthy cells alone

year 2005 Top ^

Jul.11   Genentech Profits Soar 73% in 2Q

year 2004 Top ^

Nov.4   Brisbane VaxGen gets contract for anthrax vaccine  The government is purchasing 75 million doses of a new generation vaccine under an $877.5 million Jun.8   SF Downtown 150 protesters held at biotech conference  About 200 demonstrators failed to shut down the annual Biotechnology Industry Organization convention Jun.6   SF Downtown Biotech conference opens  18,000 biotechnology scientists, executives and government officials were welcomed with a mayor and jeering protesters

year 2003 Top ^

May.19   Genentech Encouraging results with cancer drug  Avastin extended the lives of some of the colon cancer patients. Company's stock soaring nearly 45% Feb.23   Brisbane AIDS vaccine developed by VaxGen  An experimental vaccine does not protect most people, but showed promise in protecting blacks and Asians

year 2002 Top ^

Sep.7   Genentech Big patent win vs. Chiron



Add a favorite (file a bookmark) to San Francisco, Bio Tech Timeline

Please send feedback to: support@mapreport.com

Advertise on San Francisco, Bio Tech Page

To sell or purchase a home in the San Francisco complete this form